← Back to Clinical Trials
Recruiting NCT00470327
NCT00470327 A Study of the Natural Progression of Interstitial Lung Disease (ILD)
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT00470327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Interstitial Lung Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2005-09 |
| Primary Completion | 2030-12 |
Trial Parameters
Condition Interstitial Lung Diseases
Sponsor University of Chicago
Study Type OBSERVATIONAL
Phase N/A
Enrollment 4,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2005-09
Completion 2030-12
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Eligibility Criteria
Inclusion Criteria: * Interstitial lung disease Exclusion Criteria: * Does not have Interstitial lung disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology